pharmacopeia

Mechanism of action

Sourced from openFDA

Mechanism-of-action classes: Histamine H1 Receptor Antagonists; Monoamine Oxidase Inhibitors.

Histamine H1 ReceptorMonoamine Oxidase

Indications

Sourced from openFDA
  • Uses temporarily relieves these symptoms due to hay fever (allergic rhinitis) or other upper respiratory allergies: runny nose sneezing itching of the nose or throat itchy, watery eyesICD-10: J30.9

Dosage & administration

Sourced from openFDA

Directions Do not exceed recommended dosage. use only the enclosed dropper. do not use enclosed dropper for any other drug products. AGE DOSE Adutls & Children 12 years of age or older: 2 mL (2.5 mg) every 4 to 6 hours, not to exceed 8 mL (10 mg) in 24 hours or as directed by a doctor. Children 6 to under12 years of age: 1 mL (1.25 mg) every 4 to 6 hours, not to exceed 4 mL (5 mg) in 24 hours or as directed by a doctor. Children under 6 years of age: Consult a docotor.

Warnings & precautions

Sourced from openFDA

Do not exceed recommended dosage. Ask a doctor before use if the child has a breathing problem such as emphysema or chronic bronchitis glaucoma Ask a doctor before use if the child is taking sedatives or tranquilizers When using this product excitability may occur, especially in children may cause drowsiness sedatives and tranquilizers may increase the drowsiness effect Stop use and ask a doctor if new symptoms occur Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
280 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Psoriatic Arthropathy12244%
  2. 2Type 2 Diabetes Mellitus12244%
  3. 3Oedema12143%
  4. 4Pericarditis12143%
  5. 5Sinusitis12143%
  6. 6Pemphigus12043%
  7. 7Pyrexia12043%
  8. 8Joint Swelling11943%
  9. 9Urticaria11842%
  10. 10Nausea11742%
  11. 11Injury11641%
  12. 12Mobility Decreased11541%
  13. 13Pneumonia11541%
  14. 14Weight Increased11441%
  15. 15Gait Disturbance11039%

Literature

View JSON

Recent PubMed references pinned to Triprolidine as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

Frequently asked questions

How does Triprolidine work?
Mechanism-of-action classes: Histamine H1 Receptor Antagonists; Monoamine Oxidase Inhibitors.
What is Triprolidine used for?
According to FDA labeling, Triprolidine carries indications including: Uses temporarily relieves these symptoms due to hay fever (allergic rhinitis) or other upper respiratory allergies: runny nose sneezing itching of the nose or throat itchy, watery eyes. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
What class of drug is Triprolidine?
Triprolidine is classified as Other antihistamines for systemic use, Histamine H1 Receptor Antagonists, Monoamine Oxidase Inhibitors, Decreased Histamine Activity.
What are the brand names for Triprolidine?
Triprolidine is marketed under brand names including A-Phedrin, Aphedrid, Flonase Nighttime, Genac brand of pseudoephedrine/triprolidine, Pediaclear Childrens, Vi-Sudo, Wal-Act.
Note. Data for triprolidine is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients